Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2010
08/24/2010US7781457 Isoquinolinone potassium channel inhibitors
08/24/2010US7781456 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781442 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
08/24/2010US7781431 Thienopyrroles as antiviral agents
08/24/2010US7781426 cholesterol ester transfer protein (CETP) inhibitors such as (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(3,3-dimethylpiperidin-1-yl)-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one, useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis
08/24/2010CA2474031C Heterocyclic tripeptides as hepatitis c inhibitors
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2467538C New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093061A1 Diazepinedione derivative
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092660A1 Inhibitor of casein kinase 1δ and casein kinase 1ε
08/19/2010WO2010039534A3 Viral and fungal inhibitors
08/19/2010WO2009064747A3 4(-3-(-2-(phenyl) morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl) benzenesulfon amide derivatives and related compounds as modulators of ion channels for the treatment of pain
08/19/2010US20100210849 Compositions and Methods for Controlling Nematodes
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210688 Novel Benzothiazolone Derivatives
08/19/2010US20100210686 Therapeutic agents useful for treating pain
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210663 Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
08/19/2010US20100210662 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210649 Pyridazinones and furan-containing compounds
08/19/2010US20100210647 Indole compounds as an inhibitor of cellular necrosis
08/19/2010US20100210634 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210622 Heterocyclic compounds and methods of use
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210577 Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2755935A1 Hetero ring derivative
08/18/2010EP2218720A1 2-2'-Bis-thiazole derivatives as antiviral agents
08/18/2010EP2218717A1 Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
08/18/2010EP2217595A1 Diamido thiazole derivatives as protein kinase inhibitors
08/18/2010EP2217594A2 Novel pyrimidine derivatives
08/18/2010EP2217589A2 Modulators of ocular oxidative stress
08/18/2010EP2217573A1 Treating and preventing viral infections
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP1984350B1 Pyrimidine derivatives used as pi-3 kinase inhibitors
08/18/2010EP1940786B1 Biphenyl derivatives and their use in treating hepatitis c
08/18/2010EP1934203B1 3,4-dihydro-2H-benzo[1,4]oxazine and 3,4-dihydro-2H-benzo[1,4]thiazine COMPOUNDS AS ALPHA2C ADRENORECEPTOR AGONISTS
08/18/2010EP1781646B1 PROCESS FOR THE PREPARATION OF 11-(4-[2-(2-HYDROXYETHOXY)ETHYL]-1-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1735275B1 Aryl sulfones and uses related thereto
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101808994A Compounds and methods for kinase modulation, and indications therefor
08/18/2010CN101808988A Piperidine and piperazine derivatives
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101805338A Oxadiazole-based piperazine derivative and application thereof
08/18/2010CN101805328A epothilone derivatives
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7777037 condensing mixture of 5-(2-chloroethyl)-6-chlorooxindole, 5-(2-chloroacetyl)-6-chloro-2-oxindole, and 5-(2-chlorohydroxylethyl)-6-chlorooxindole with 3-(1-piperazinyl)-1,2-benzisothiazole to form mixture of ziprasidone and impurities, and purifying ziprasidone by slurrying, recrystallization
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776529 For fluorescent detection/quantitation of DNA; kits; staining solutions
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2460160C Thiazolyl substituted aminopyrimidines as plant protection agents
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/17/2010CA2407208C Process for producing optically active sulfoxide derivative
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2370412C Pharmaceutical compounds
08/12/2010WO2010091310A1 Inhibitors of jun n-terminal kinase
08/12/2010WO2010091176A1 Phthalazine-containing antidiabetic compounds
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2010090344A1 Hydrazide compound and use of the same in pest control
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010089303A1 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
08/12/2010WO2010089211A1 Novel herbicides
08/12/2010WO2010069280A3 A method for the preparation of tizanidine hydrochloride
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204240 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
08/12/2010US20100204237 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204231 Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010US20100204159 Organic compounds and their uses
08/12/2010US20100200054 Compound for organic photoelectric device and organic photoelectric device including the same
08/12/2010CA2751481A1 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010CA2751441A1 Novel herbicides
08/12/2010CA2751141A1 Inhibitors of jun n-terminal kinase
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 628